A Metabolic Vulnerability of Small-cell Lung Cancer
Overview
Authors
Affiliations
Cross-omics strategies and personalised options for lung cancer immunotherapy.
Yan Y, Shen S, Li J, Su L, Wang B, Zhang J Front Immunol. 2024; 15:1471409.
PMID: 39391313 PMC: 11465239. DOI: 10.3389/fimmu.2024.1471409.
Dichloroacetate for Cancer Treatment: Some Facts and Many Doubts.
Koltai T, Fliegel L Pharmaceuticals (Basel). 2024; 17(6).
PMID: 38931411 PMC: 11206832. DOI: 10.3390/ph17060744.
Actionable Driver Events in Small Cell Lung Cancer.
Gutierrez M, Zamora I, Freeman M, Encio I, Rotinen M Int J Mol Sci. 2024; 25(1).
PMID: 38203275 PMC: 10778712. DOI: 10.3390/ijms25010105.
Miglietta S, Girolimetti G, Marchio L, Sollazzo M, Laprovitera N, Coluccelli S Noncoding RNA. 2022; 8(5).
PMID: 36287116 PMC: 9611163. DOI: 10.3390/ncrna8050064.
Krencz I, Sztankovics D, Danko T, Sebestyen A, Khoor A Cancer Metastasis Rev. 2021; 40(4):1141-1157.
PMID: 34958428 PMC: 8825381. DOI: 10.1007/s10555-021-10012-4.